Abstract
BackgroundSeveral studies suggest that pramipexole, a dopamine agonist approved for the treatment of Parkinson’s disease and restless legs syndrome, may possess antidepressant properties.PurposeThe objective was to assess the off-label prescriptions...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have